{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:06:55Z","timestamp":1772806015604,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF2011-22771"],"award-info":[{"award-number":["SAF2011-22771"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF2014-52632-R"],"award-info":[{"award-number":["SAF2014-52632-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FPU"},{"name":"AVTE"},{"name":"USC"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.actbio.2016.05.032","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T22:32:45Z","timestamp":1464042765000},"page":"302-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis"],"prefix":"10.1016","volume":"41","author":[{"given":"Clara","family":"Gonz\u00e1lez-Chom\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-049X","authenticated-orcid":false,"given":"Angel","family":"Concheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8546-7085","authenticated-orcid":false,"given":"Carmen","family":"Alvarez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.05.032_b0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10792-004-1818-x","article-title":"A review of the use of olopatadine in allergic conjunctivitis","volume":"25","author":"McGill","year":"2004","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.05.032_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clae.2011.08.009","article-title":"A review of non-pharmacological and pharmacological management of seasonal and perennial allergic conjunctivitis","volume":"35","author":"Bilkhu","year":"2012","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.actbio.2016.05.032_b0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0149-2918(03)80115-7","article-title":"A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis","volume":"25","author":"Abelson","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.actbio.2016.05.032_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1824-7288-39-18","article-title":"Allergic conjunctivitis: a comprehensive review of the literature","volume":"39","author":"La Rosa","year":"2013","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.actbio.2016.05.032_b0025","first-page":"112","article-title":"Comprehensive review of olopatadine: the molecule and its clinical entities","volume":"31","author":"Kaliner","year":"2010","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.actbio.2016.05.032_b0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajo.2010.10.001","article-title":"Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis","volume":"151","author":"Shimura","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.actbio.2016.05.032_b0035","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0149-2918(02)80060-1","article-title":"A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis","volume":"24","author":"Katelaris","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.actbio.2016.05.032_b0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/14656561003694643","article-title":"Olopatadine: a drug for allergic conjunctivitis targeting the mast cell","volume":"11","author":"Leonardi","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.actbio.2016.05.032_b0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1076\/ocii.11.4.247.18261","article-title":"Interactions of olopatadine and selected antihistamines with model and natural membranes","volume":"11","author":"Brockman","year":"2003","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.actbio.2016.05.032_b0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/erd.09.4","article-title":"Drug delivery systems for the eye","volume":"6","author":"Kearns","year":"2009","journal-title":"Exp. Rev. Med. Devices"},{"key":"10.1016\/j.actbio.2016.05.032_b0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","article-title":"Recent advances in ophthalmic drug delivery","volume":"1","author":"Kompella","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2016.05.032_b0060","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4155\/tde.13.81","article-title":"Soft contact lenses for controlled ocular delivery: 50years in the making","volume":"4","author":"Gonz\u00e1lez-Chom\u00f3n","year":"2013","journal-title":"Ther. Del."},{"key":"10.1016\/j.actbio.2016.05.032_b0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/02713683.2014.917192","article-title":"Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses","volume":"40","author":"Hsu","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.actbio.2016.05.032_b0070","doi-asserted-by":"crossref","first-page":"e106653","DOI":"10.1371\/journal.pone.0106653","article-title":"Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models","volume":"9","author":"Mohammadi","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2016.05.032_b0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1773-2247(11)50062-0","article-title":"Controlled drug release from contact lenses: a comprehensive review from 1965-present","volume":"21","author":"White","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.actbio.2016.05.032_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1600-0420.2000.078s230016.x","article-title":"A laboratory model to determine the uptake and release of olopatadine by soft contact lenses","volume":"78","author":"Dassanayake","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.actbio.2016.05.032_b0085","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.biomaterials.2006.09.007","article-title":"Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics","volume":"28","author":"Venkatesh","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.05.032_b0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clae.2011.03.004","article-title":"Role of contact lenses in relieving ocular allergy","volume":"34","author":"Wolffsohn","year":"2011","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.actbio.2016.05.032_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.ICL.0000063576.32087.F7","article-title":"Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model","volume":"29","author":"Brodsky","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.actbio.2016.05.032_b0100","unstructured":"U.S. National Institute of Health. Safety study of a contact lens with ketotifen in healthy, normal volunteers, Vistakon Pharmaceuticals, Online, 2015 October, Available from URL: <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00889252>."},{"key":"10.1016\/j.actbio.2016.05.032_b0105","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1002\/jps.24537","article-title":"Imprinted contact lenses for sustained release of polymyxin B and related antimicrobial peptides","volume":"104","author":"Malakooti","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2016.05.032_b0110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/bm101562v","article-title":"Bioinspired imprinted pHEMA-hydrogels for ocular delivery of carbonic anhydrase inhibitor drugs","volume":"12","author":"Ribeiro","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.05.032_b0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejpb.2012.01.015","article-title":"In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow","volume":"81","author":"Tieppo","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2016.05.032_b0120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biomaterials.2004.04.030","article-title":"Ocular release of timolol from molecularly imprinted soft contact lenses","volume":"26","author":"Hiratani","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.05.032_b0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2011.09.087","article-title":"Sustained in vivo release from imprinted therapeutic contact lenses","volume":"157","author":"Tieppo","year":"2012","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.05.032_b0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.memsci.2011.08.030","article-title":"Receptor-based biomimetic NVP\/DMA contact lenses for loading\/eluting carbonic anhydrase inhibitors","volume":"383","author":"Ribeiro","year":"2011","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.actbio.2016.05.032_b0135","series-title":"Biopharmaceutics of Ocular Drug Delivery","first-page":"1","article-title":"Anatomy and physiology of the eye. Physiological aspects of ocular drug therapy","author":"Stjernschantz","year":"1993"},{"key":"10.1016\/j.actbio.2016.05.032_b0140","unstructured":"U.S. National Toxicology Program. Department of Health and Human Services, Evaluation of in vitro test methods to identify ocular corrosives and severe irritants. Appendix G: ICCVAM Recommended HET-CAM Test Method Protocol, Online, 2015 October, Available from URL: <http:\/\/ntp.niehs.nih.gov\/pubhealth\/evalatm\/test-method-evaluations\/ocular\/in-vitro\/tmer\/index.html>."},{"key":"10.1016\/j.actbio.2016.05.032_b0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1015887213431","article-title":"Hydrogels: swelling, drug loading, and release","volume":"9","author":"Kim","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2016.05.032_b0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.170.1.245","article-title":"Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines","volume":"170","author":"Burd","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actbio.2016.05.032_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature10236","article-title":"Structure of the human histamine H1 receptor complex with doxepin","volume":"475","author":"Shimamura","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2016.05.032_b0160","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1006\/bbrc.1994.2295","article-title":"Site-directed mutagenesis of the histamine H1 receptors: roles of aspartic acid107, asparagine198 and threonine194","volume":"203","author":"Ohta","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2016.05.032_b0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2006.05.003","article-title":"Imprinted soft contact lenses as norfloxacin delivery systems","volume":"113","author":"Alvarez-Lorenzo","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.05.032_b0170","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/ac0345345","article-title":"Characterization of the imprint effect and the influence of imprinting conditions on affinity, capacity, and heterogeneity in molecularly imprinted polymers using the Freundlich isotherm-affinity distribution analysis","volume":"76","author":"Rampey","year":"2004","journal-title":"Anal. Chem."},{"key":"10.1016\/j.actbio.2016.05.032_b0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1034\/j.1600-0420.2000.078s230056.x","article-title":"Allergic conjunctivitis and contact lenses: experience with olopatadine hydrochloride 0.1% therapy","volume":"78","author":"Brodsky","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.actbio.2016.05.032_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1084\/jem.174.1.103","article-title":"Release of both preformed and newly synthesized tumor necrosis factor \u03b1 (TNF-\u03b1)\/cachectin by mouse mast cells stimulated via the Fc\u0190RI. A mechanism for the sustained action of mast cell-derived TNF-\u03b1 during IgE-dependent biological responses","volume":"174","author":"Gordon","year":"1991","journal-title":"J. Exp. Med."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116302501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116302501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:52:16Z","timestamp":1761670336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116302501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":36,"alternative-id":["S1742706116302501"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.05.032","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic contact lenses eluting olopatadine for allergic conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}